This Article Full Text Full Text (PDF) All Versions of this Article: 92/1/363    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grarup, N. Articles by Pedersen, O. Search for Related Content PubMed PubMed Citation Articles by Grarup, N. Articles by Pedersen, O. Related Collections Thyroid Metabolism

Studies of the Common DIO2 Thr92Ala Polymorphism and Metabolic Phenotypes in 7342 Danish White Subjects

Steno Diabetes Center (N.G., M.K.A., C.H.A., A.A., K.B.-J., T.H., O.P.), 2820 Gentofte, Copenhagen, Denmark; Faculty of Health Sciences (N.G., K.B.-J., O.P.), University of Aarhus, 8000 Aarhus C, Denmark; Research Centre for Prevention and Health (K.B.-J., T.J.), Glostrup University Hospital, 2600 Glostrup, Denmark; Institut de Génétique et Biologie Moléculaire et Cellulaire (J.A.), Centre National de la Recherche Scientifique/Institut National de la Santé et de la Recherche Médicale/Université Louis Pasteur Strasbourg, 67404 Illkirch Cedex, France; Institut Clinique de la Souris (J.A.), 67404 Illkirch Cedex, France; Department of Endocrinology and Diabetes M (O.S.), Aarhus University Hospital, Aarhus Sygehus, 8000 Aarhus C, Denmark; and Department of Clinical Pharmacology (O.S.), University of Aarhus, 8000 Aarhus C, Denmark

Address all correspondence and requests for reprints to: Niels Grarup, Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark. E-mail: ngrp{at}steno.dk.

Context: The type 2 iodothyronine deiodinase (D2) catalyzes the conversion of T₄ to the active form of thyroid hormone, which is a critical regulator of thermogenesis and glucose metabolism. A Thr92Ala polymorphism in the gene encoding D2 (DIO2) has been reported to associate with insulin resistance.

Objective: The aim of the present study was to assess the impact of the DIO2 Thr92Ala variant on type 2 diabetes (T2D), obesity, and related quantitative metabolic traits including measures of insulin resistance. Because DIO2 is activated through a ß-adrenergic receptor-dependent pathway, we further hypothesized that variation in the ADRB genes interacts with DIO2 Thr92Ala variant to influence metabolic traits.

Design and Patients: The DIO2 polymorphism was genotyped in a total of 7342 white subjects including 1405 T2D patients.

Results: We detected no significant association of the DIO2 Thr92Ala polymorphism with T2D or obesity. We observed nominal significant associations of genotype with increased area under the serum insulin curve during an oral glucose tolerance test (P = 0.03) and elevated fasting plasma glucose (P = 0.02) in homozygous Ala92 allele carriers, the latter strengthened by epistasis with the ADRB2 Gly16Arg variant in a double recessive model (P = 0.004). However, after permutation procedure, performed to correct for multiple hypothesis testing, the associations did not reach study-wide significance.

Conclusions: The DIO2 Thr92Ala variant does not confer an increased risk of T2D, obesity, or insulin resistance.

This article has been cited by other articles:

				L. H. Canani, M. A. Leie, W. E. Machado, C. Capp, and A. L. Maia Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated With Arterial Hypertension in Type 2 Diabetes Mellitus Patients Hypertension, June 1, 2007; 49(6): e47 - e47. [Full Text] [PDF]